[Prognostic factors in idiopathic pulmonary fibrosis in a tunisian cohort]

Rev Mal Respir. 2021 Sep;38(7):681-688. doi: 10.1016/j.rmr.2021.04.015. Epub 2021 May 12.
[Article in French]

Abstract

We present data on prognostic factors in a Tunisian cohort of people with Idiopathic pulmonary fibrosis.

Introduction: Idiopathic pulmonary fibrosis (IPF) has a poor prognosis, with a median survival in patients with the condition of only 3 to 5 years. Previous studies have identified a number of prognostic factors in this chronic pulmonary disease.

Methods: We conducted a retrospective study, including patients with idiopathic pulmonary fibrosis (IPF) who were diagnosed at the Pneumology Department of the University Hospital Fattouma-Bourguiba, Monastir, between 1991 and 2014. The aim of this study was to compare clinical, radiological, pulmonary functional predictors of survival in IPF in a Tunisian cohort with those of previous studies.

Results: This study included 126 patients. Their mean age was 66 years, with a male predominance (68.3%). Respiratory function tests revealed a restrictive ventilatory deficit in 72.6% of cases. The median survival of our study population was 22.5 months [6.7-49.5]. In univariate analysis, factors associated with a poor prognosis were: lower baseline values of TLC, FCV and DLco, level of dyspnea assessed by mMRC scale, hypoxemia at diagnosis, the degree of desaturation during exercise, a higher annual decline of FVC and DLco, acute respiratory distress and also the GAP score. In multivariate analysis, independent prognostic factors were: baseline DLco, level of dyspnea, desaturation at exertion and the annual decline of the DLco.

Conclusion: Lower baseline DLco, the level of dyspnea, desaturation on exercise, and annual decline in DLco are all associated with a poor prognosis in IPF.

Keywords: Chest computed tomography; Fibrose pulmonaire idiopathique; Idiopathic pulmonary fibrosis; Prognosis; Pronostic; Survie; Survival; Tomodensitométrie thoracique.

MeSH terms

  • Aged
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis* / diagnosis
  • Idiopathic Pulmonary Fibrosis* / epidemiology
  • Male
  • Prognosis
  • Respiratory Function Tests
  • Retrospective Studies
  • Survival Rate